Omeros (OMER) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.69% |
| Dec 31, 2025 | -1.65% |
| Sep 30, 2025 | -35.27% |
| Jun 30, 2025 | 70.36% |
| Mar 31, 2025 | -9.71% |
| Dec 31, 2024 | 1.86% |
| Sep 30, 2024 | 69.14% |
| Jun 30, 2024 | 108.84% |
| Mar 31, 2024 | 124.33% |
| Dec 31, 2023 | 3.79% |
| Sep 30, 2023 | 61.52% |
| Jun 30, 2023 | 18.02% |
| Mar 31, 2023 | 26.16% |
| Dec 31, 2022 | 26.53% |
| Sep 30, 2022 | 192.85% |
| Jun 30, 2022 | 33.02% |
| Mar 31, 2022 | 156.45% |
| Dec 31, 2021 | 114.42% |
| Sep 30, 2021 | -6.36% |
| Jun 30, 2021 | 22.58% |
| Mar 31, 2021 | 55.88% |
| Dec 31, 2020 | 50.39% |
| Sep 30, 2020 | 103.69% |
| Jun 30, 2020 | -4.82% |
| Mar 31, 2020 | 37.57% |
| Dec 31, 2019 | 54.34% |
| Sep 30, 2019 | 64.01% |
| Jun 30, 2019 | 21.14% |
| Mar 31, 2019 | 48.20% |
| Dec 31, 2018 | 33.64% |
| Sep 30, 2018 | 19.37% |
| Jun 30, 2018 | 10.93% |
| Mar 31, 2018 | -7.07% |
| Dec 31, 2017 | 17.43% |
| Sep 30, 2017 | -0.65% |
| Jun 30, 2017 | -14.17% |
| Mar 31, 2017 | -40.23% |
| Dec 31, 2016 | -11.10% |
| Sep 30, 2016 | 16.07% |
| Jun 30, 2016 | 1.99% |
| Mar 31, 2016 | -24.25% |
| Dec 31, 2015 | -16.07% |
| Sep 30, 2015 | -26.47% |
| Jun 30, 2015 | -2.27% |